BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells. Yu Y, Xiao Z, Lei C, Ma C, et al. BMC Cancer 2023;23:732.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu Y, Xiao Z, Lei C, Ma C, et al. BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells. BMC Cancer 2023;23:732.
PMID: 37553597